Publications

Our people

Filter publications

What type of publication do you want to show?

All

Journals

Conference papers

Chapters

Books

Other

2025

Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Stott, K. E., Tembo, D., Kajanga, C., Ahmadu, A., Namakhwa, D., Kolamunnage-Dona, R., . . . AMBITION Study Group. (2025). Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.. Open Forum Infect Dis, 12(4), ofaf190. doi:10.1093/ofid/ofaf190

DOI: 10.1093/ofid/ofaf190
: Journal article

2024

Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.

Hanif, M., Sarker, C., Al-Abadi, E., Armon, K., Bailey, K., Bohm, M., . . . Smith, E. M. D. (2024). Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.. Rheumatology (Oxford, England), keae592. doi:10.1093/rheumatology/keae592

DOI: 10.1093/rheumatology/keae592
: Journal article

OP0246 FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY

Hanif, M., Sarker, C., Beresford, M. W., & MD Smith, E. (2024). OP0246 FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY. In Annals of the Rheumatic Diseases Vol. 83 (pp. 227-228). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.1166

DOI: 10.1136/annrheumdis-2024-eular.1166
: Conference Paper

OP0277 EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL

Sarker, C., Jorgensen, A. L., Beresford, M. W., & MD Smith, E. (2024). OP0277 EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL. In Annals of the Rheumatic Diseases Vol. 83 (pp. 229). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.697

DOI: 10.1136/annrheumdis-2024-eular.697
: Conference Paper

POS0173 EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS

Smith, E. M., Sarker, C., Jorgensen, A. L., & Beresford, M. W. (2024). POS0173 EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS. In Annals of the Rheumatic Diseases Vol. 83 (pp. 529). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.5896

DOI: 10.1136/annrheumdis-2024-eular.5896
: Conference Paper